Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125461652 | 12546165 | 2 | F | 20160623 | 20160726 | 20160711 | 20160808 | EXP | IT-CELGENEUS-ITA-2016066243 | CELGENE | 75.00 | YR | M | Y | 0.00000 | 20160808 | OT | IT | IT |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
125461652 | 12546165 | 1 | PS | REVLIMID | LENALIDOMIDE | 1 | Oral | 25 MICROGRAM | U | 21880 | 25 | UG | CAPSULES | QD | |||||
125461652 | 12546165 | 2 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | U | 0 | 20 | UG | UNKNOWN |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
125461652 | 12546165 | 1 | Plasma cell myeloma |
125461652 | 12546165 | 2 | Plasma cell myeloma |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
125461652 | 12546165 | DE |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
125461652 | 12546165 | Acute pulmonary oedema | |
125461652 | 12546165 | Respiratory failure |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
125461652 | 12546165 | 1 | 20160412 | 20160623 | 0 | |
125461652 | 12546165 | 2 | 20160412 | 20160623 | 0 |